Mosquitoes have been widely responsible for the spread of two major diseases in the underdeveloped world – malaria and dengue. Around 240 million instances of malaria were estimated globally as of 2020, of which 627 000 resulted in fatalities, according to the World Health Organization (WHO) [1]. On the other hand, WHO estimates that there are […]
Monkeypox (MPX), caused by the Monkeypox virus (MPXV), is an endemic disease in African countries and is currently causing outbreaks in several European regions, amidst a recent surge in new COVID-19 cases. This can significantly impact already exhausted healthcare services, adding on to the economic and social burdens in the region. A lack of sufficient laboratory diagnostics, antivirals, vaccines may hinder effective clinical management of affected patients. Therefore, it is essential to increase awareness about MPX and its transmission among the general population, to ensure necessary precautions are taken and new cases are reported swiftly. This article discusses the impact of MPXV on the current reemergence of COVID-19 in Europe, lessons learnt during the COVID-19 pandemic and recommendations to address potential challenges.
1 January 2022 in Journal of Pediatric Surgery Case Reports